Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 PLXNB2 FAT2 TENM3 PTPRM PLXNB3	1.36e-05	187	157	9	GO:0007156
GeneOntologyBiologicalProcess	neuron projection development	CARM1 FAT4 ATP8A2 SEMA5A LAMC2 CRTAC1 NLGN1 CSMD3 PLXNB2 ZNF365 TIAM2 TBC1D24 GRIP1 LIF TENM3 IFT88 PTPRM GLI3 IQSEC1 NLGN2 CAMSAP2 MYO16 PLXNB3 LGI1 NCKAP1L	1.37e-05	1285	157	25	GO:0031175
GeneOntologyBiologicalProcess	positive regulation of nervous system development	SEMA5A NLGN1 PLXNB2 ZNF365 TIAM2 TBC1D24 GRIP1 LIF LIG4 GLI3 IQSEC1 NLGN2 PLXNB3	1.96e-05	418	157	13	GO:0051962
GeneOntologyBiologicalProcess	neuron development	CARM1 FAT4 ATP8A2 SEMA5A LAMC2 CRTAC1 NLGN1 CSMD3 PLXNB2 ZNF365 OPCML TIAM2 TBC1D24 GRIP1 LIF TENM3 IFT88 PTPRM GLI3 IQSEC1 NLGN2 CAMSAP2 MYO16 PLXNB3 LGI1 NCKAP1L	4.29e-05	1463	157	26	GO:0048666
GeneOntologyBiologicalProcess	protein poly-ADP-ribosylation	PARP14 TNKS TNKS2	6.83e-05	11	157	3	GO:0070212
MousePheno	abnormal medulla oblongata morphology	ATRN GALC CACNA2D2 GLI3 RORA	3.62e-06	26	130	5	MP:0000846
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.93e-09	4	158	4	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.93e-09	4	158	4	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.93e-09	4	158	4	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.93e-09	4	158	4	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.93e-09	4	158	4	IPR015753
Domain	Plexin_repeat	ATRN PLXDC1 SEMA5A PLXNB2 MST1R ATRNL1 PLXNB3	7.65e-09	32	158	7	IPR002165
Domain	PSI	ATRN PLXDC1 SEMA5A PLXNB2 MST1R ATRNL1 PLXNB3	7.65e-09	32	158	7	PF01437
Domain	ConA-like_dom	CNTNAP3B FAT4 TMPRSS15 TRIM58 CNTNAP3 CMYA5 MEP1B FAT2 PTPRM CNTNAP4 COL14A1 WDFY3 USH2A	4.60e-08	219	158	13	IPR013320
Domain	PSI	ATRN PLXDC1 SEMA5A PLXNB2 MST1R ATRNL1 PLXNB3	1.10e-07	46	158	7	SM00423
Domain	EGF_1	ATRN CNTNAP3B FAT4 CNTNAP3 LAMC2 CRTAC1 PTGS1 MEP1B FAT2 TENM3 ATRNL1 CNTNAP4 USH2A	2.70e-07	255	158	13	PS00022
Domain	Laminin_G	CNTNAP3B FAT4 CNTNAP3 FAT2 CNTNAP4 COL14A1 USH2A	5.68e-07	58	158	7	IPR001791
Domain	LAM_G_DOMAIN	CNTNAP3B FAT4 CNTNAP3 FAT2 CNTNAP4 USH2A	7.36e-07	38	158	6	PS50025
Domain	Laminin_G_2	CNTNAP3B FAT4 CNTNAP3 FAT2 CNTNAP4 USH2A	1.01e-06	40	158	6	PF02210
Domain	EGF-like_dom	ATRN CNTNAP3B FAT4 CNTNAP3 LAMC2 CRTAC1 PTGS1 MEP1B FAT2 TENM3 ATRNL1 CNTNAP4	1.43e-06	249	158	12	IPR000742
Domain	PSI	ATRN SEMA5A PLXNB2 MST1R ATRNL1 PLXNB3	1.80e-06	44	158	6	IPR016201
Domain	LamG	CNTNAP3B FAT4 CNTNAP3 FAT2 CNTNAP4 USH2A	1.80e-06	44	158	6	SM00282
Domain	EGF_2	ATRN CNTNAP3B FAT4 CNTNAP3 LAMC2 CRTAC1 PTGS1 MEP1B FAT2 TENM3 ATRNL1 CNTNAP4	2.73e-06	265	158	12	PS01186
Domain	EGF	ATRN CNTNAP3B FAT4 CNTNAP3 LAMC2 PTGS1 MEP1B FAT2 TENM3 ATRNL1 CNTNAP4	5.25e-06	235	158	11	SM00181
Domain	EGF_3	ATRN CNTNAP3B FAT4 CNTNAP3 CRTAC1 PTGS1 MEP1B FAT2 TENM3 ATRNL1 CNTNAP4	5.25e-06	235	158	11	PS50026
Domain	EGF-like_CS	ATRN FAT4 CNTNAP3 LAMC2 CRTAC1 PTGS1 MEP1B FAT2 TENM3 ATRNL1 CNTNAP4	1.41e-05	261	158	11	IPR013032
Domain	EGF_LAM_2	ATRN LAMC2 ATRNL1 USH2A	1.14e-04	30	158	4	PS50027
Domain	EGF_LAM_1	ATRN LAMC2 ATRNL1 USH2A	1.14e-04	30	158	4	PS01248
Domain	Semap_dom	SEMA5A PLXNB2 MST1R PLXNB3	1.30e-04	31	158	4	IPR001627
Domain	SEMA	SEMA5A PLXNB2 MST1R PLXNB3	1.30e-04	31	158	4	PS51004
Domain	Sema	SEMA5A PLXNB2 MST1R PLXNB3	1.30e-04	31	158	4	SM00630
Domain	Sema	SEMA5A PLXNB2 MST1R PLXNB3	1.30e-04	31	158	4	PF01403
Domain	Galactose-bd-like	CNTNAP3B CNTNAP3 MEP1B PTPRM GUSB CNTNAP4	1.47e-04	94	158	6	IPR008979
Domain	Sugar_transporter_CS	SLC2A1 SLC2A4 SLC2A5 SV2A	1.47e-04	32	158	4	IPR005829
Domain	-	FAT4 CNTNAP3 FAT2 CNTNAP4 WDFY3 USH2A	1.56e-04	95	158	6	2.60.120.200
Domain	Sugar/inositol_transpt	SLC2A1 SLC2A4 SLC2A5	2.02e-04	14	158	3	IPR003663
Domain	EGF_Lam	ATRN LAMC2 ATRNL1 USH2A	2.10e-04	35	158	4	SM00180
Domain	MFS_sugar_transport-like	SLC2A1 SLC2A4 SLC2A5 SV2A	2.35e-04	36	158	4	IPR005828
Domain	Sugar_tr	SLC2A1 SLC2A4 SLC2A5 SV2A	2.35e-04	36	158	4	PF00083
Domain	Laminin_EGF	ATRN LAMC2 ATRNL1 USH2A	2.91e-04	38	158	4	IPR002049
Domain	MAM_1	TMPRSS15 MEP1B PTPRM	3.07e-04	16	158	3	PS00740
Domain	Poly(ADP-ribose)pol_cat_dom	PARP14 TNKS TNKS2	3.70e-04	17	158	3	IPR012317
Domain	PARP_CATALYTIC	PARP14 TNKS TNKS2	3.70e-04	17	158	3	PS51059
Domain	PARP	PARP14 TNKS TNKS2	3.70e-04	17	158	3	PF00644
Domain	-	PARP14 TNKS TNKS2	3.70e-04	17	158	3	3.90.228.10
Domain	MAM	TMPRSS15 MEP1B PTPRM	3.70e-04	17	158	3	SM00137
Domain	SUGAR_TRANSPORT_2	SLC2A1 SLC2A4 SLC2A5	3.70e-04	17	158	3	PS00217
Domain	MAM	TMPRSS15 MEP1B PTPRM	4.42e-04	18	158	3	PF00629
Domain	MAM_dom	TMPRSS15 MEP1B PTPRM	4.42e-04	18	158	3	IPR000998
Domain	MAM_2	TMPRSS15 MEP1B PTPRM	4.42e-04	18	158	3	PS50060
Domain	Biotin_BS	ACACB PC	6.99e-04	5	158	2	IPR001882
Domain	Biotin_COase_C	ACACB PC	6.99e-04	5	158	2	IPR005482
Domain	BC	ACACB PC	6.99e-04	5	158	2	PS50979
Domain	Nlgn	NLGN1 NLGN2	6.99e-04	5	158	2	IPR000460
Domain	Biotin_carb_C	ACACB PC	6.99e-04	5	158	2	SM00878
Domain	Biotin_carb_C	ACACB PC	6.99e-04	5	158	2	PF02785
Domain	Biotin_carboxylation_dom	ACACB PC	6.99e-04	5	158	2	IPR011764
Domain	BIOTIN	ACACB PC	6.99e-04	5	158	2	PS00188
Domain	FA58C	CNTNAP3B CNTNAP3 CNTNAP4	7.06e-04	21	158	3	SM00231
Domain	FA58C_3	CNTNAP3B CNTNAP3 CNTNAP4	7.06e-04	21	158	3	PS50022
Domain	FA58C_1	CNTNAP3B CNTNAP3 CNTNAP4	7.06e-04	21	158	3	PS01285
Domain	FA58C_2	CNTNAP3B CNTNAP3 CNTNAP4	7.06e-04	21	158	3	PS01286
Domain	EGF	ATRN CNTNAP3 PTGS1 MEP1B FAT2 CNTNAP4	7.12e-04	126	158	6	PF00008
Domain	CUB	ATRN TMPRSS15 CSMD3 ATRNL1	7.77e-04	49	158	4	PF00431
Domain	CUB	ATRN TMPRSS15 CSMD3 ATRNL1	8.39e-04	50	158	4	SM00042
Domain	-	ATRN TMPRSS15 CSMD3 ATRNL1	9.73e-04	52	158	4	2.60.120.290
Domain	Rudment_hybrid_motif	ACACB PC	1.04e-03	6	158	2	IPR011054
Domain	CUB	ATRN TMPRSS15 CSMD3 ATRNL1	1.05e-03	53	158	4	PS01180
Domain	F5_F8_type_C	CNTNAP3B CNTNAP3 CNTNAP4	1.06e-03	24	158	3	PF00754
Domain	FA58C	CNTNAP3B CNTNAP3 CNTNAP4	1.06e-03	24	158	3	IPR000421
Domain	SUGAR_TRANSPORT_1	SLC2A1 SLC2A4 SLC2A5	1.06e-03	24	158	3	PS00216
Domain	WGR_domain	PARP14 TNKS TNKS2	1.06e-03	24	158	3	IPR008893
Domain	CUB_dom	ATRN TMPRSS15 CSMD3 ATRNL1	1.37e-03	57	158	4	IPR000859
Domain	CbamoylP_synth_lsu-like_ATP-bd	ACACB PC	1.45e-03	7	158	2	IPR005479
Domain	BC-like_N	ACACB PC	1.45e-03	7	158	2	IPR005481
Domain	CPSase_L_D2	ACACB PC	1.45e-03	7	158	2	PF02786
Domain	Znf_GRF	APEX2 NEIL3	1.45e-03	7	158	2	IPR010666
Domain	zf-GRF	APEX2 NEIL3	1.45e-03	7	158	2	PF06839
Domain	Biotin_carb_N	ACACB PC	1.45e-03	7	158	2	PF00289
Domain	IPT	PLXNB2 MST1R PLXNB3	1.50e-03	27	158	3	SM00429
Domain	-	SEMA5A DNAI3 PLXNB2 MST1R CDC40 TAF5L WDFY3 PLXNB3 WDR24	2.15e-03	333	158	9	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	SEMA5A DNAI3 PLXNB2 MST1R CDC40 TAF5L WDFY3 PLXNB3 WDR24	2.24e-03	335	158	9	IPR015943
Domain	Alkaline_phosphatase_core	PIGN ARSJ SULF1	2.24e-03	31	158	3	IPR017850
Domain	Alkaline_Pase-like_a/b/a	PIGN ARSJ SULF1	2.24e-03	31	158	3	IPR017849
Domain	-	PIGN ARSJ SULF1	2.24e-03	31	158	3	3.40.720.10
Domain	TIG	PLXNB2 MST1R PLXNB3	2.24e-03	31	158	3	PF01833
Domain	Cadherin_CS	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 FAT2	2.34e-03	109	158	5	IPR020894
Domain	IPT	PLXNB2 MST1R PLXNB3	2.46e-03	32	158	3	IPR002909
Domain	FIBRINOGEN_C_1	CNTNAP3B CNTNAP3 CNTNAP4	2.46e-03	32	158	3	PS00514
Domain	-	ATP13A1 ATP8A2 ATP4A	2.46e-03	32	158	3	3.40.1110.10
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP3B CNTNAP3 CNTNAP4	2.46e-03	32	158	3	IPR002181
Domain	-	ATP13A1 ATP8A2 ATP4A	2.46e-03	32	158	3	2.70.150.10
Domain	FIBRINOGEN_C_2	CNTNAP3B CNTNAP3 CNTNAP4	2.46e-03	32	158	3	PS51406
Domain	Plexin_cytopl	PLXNB2 PLXNB3	2.46e-03	9	158	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNB2 PLXNB3	2.46e-03	9	158	2	IPR013548
Domain	Plexin	PLXNB2 PLXNB3	2.46e-03	9	158	2	IPR031148
Domain	Biotin_lipoyl	ACACB PC	2.46e-03	9	158	2	PF00364
Domain	CADHERIN_1	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 FAT2	2.74e-03	113	158	5	PS00232
Domain	Cadherin	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 FAT2	2.74e-03	113	158	5	PF00028
Domain	CADHERIN_2	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 FAT2	2.85e-03	114	158	5	PS50268
Domain	-	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 FAT2	2.85e-03	114	158	5	2.60.40.60
Domain	CA	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 FAT2	2.96e-03	115	158	5	SM00112
Domain	BIOTINYL_LIPOYL	ACACB PC	3.06e-03	10	158	2	PS50968
Domain	Biotin_lipoyl	ACACB PC	3.06e-03	10	158	2	IPR000089
Domain	Cadherin-like	FAT4 PCDHGA11 PCDHGA10 PCDHGA4 FAT2	3.07e-03	116	158	5	IPR015919
Domain	ATPase_P-typ_cyto_domN	ATP13A1 ATP8A2 ATP4A	3.19e-03	35	158	3	IPR023299
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	9.79e-08	10	164	4	23064749
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	4.10e-07	4	164	3	22419166
Pubmed	The Axin/TNKS complex interacts with KIF3A and is required for insulin-stimulated GLUT4 translocation.	SLC2A4 TNKS TNKS2	1.02e-06	5	164	3	22473005
Pubmed	Interplay between scatter factor receptors and B plexins controls invasive growth.	PLXNB2 MST1R PLXNB3	1.02e-06	5	164	3	15184888
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TET2 ANXA11 DARS1 ODF2 SLC2A1 SLC38A1 VPS13D CD9 TENM3 SCAF11 WDFY3 ACCSL IPO11	1.77e-06	536	164	13	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TET2 ANXA11 DARS1 ODF2 SLC2A1 SLC38A1 VPS13D CD9 TENM3 SCAF11 WDFY3 ACCSL IPO11	1.84e-06	538	164	13	10512203
Pubmed	Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).	ACACB SLC2A1 SLC2A4 SLC2A5	3.26e-06	22	164	4	20965718
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TCF20 DOCK9 NLGN1 CSMD3 ZNF365 SACM1L TENM3 SV2A CAMSAP2 TMEM181 PLXNB3	4.09e-06	407	164	11	12693553
Pubmed	A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis.	SLC2A1 SLC2A4 IFT88 GLI3 AHR	5.24e-06	53	164	5	38466355
Pubmed	POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.	XCR1 PLXDC1 PSMD3 DARS1 CMYA5 DDX5 VPS13D CD9 EIF3L	7.31e-06	277	164	9	30745168
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ATRN LRRC37A3 CACNA2D2 SPTLC2 LRRC37A ATRNL1	1.10e-05	105	164	6	9628581
Pubmed	Defining the membrane proteome of NK cells.	PPP1R21 PIGN ATP13A1 CNOT10 DOCK9 ANXA11 ELOVL5 PSMD3 DARS1 PARP14 DDX5 GUSB EIF3L IQSEC1 DHX34 HNRNPLL G6PD NCKAP1L	1.12e-05	1168	164	18	19946888
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CACNA2D2 ATP13A1 PSMD3 DARS1 CMYA5 SLC2A1 DDX5 SACM1L SLC38A1 CDC40 PABPN1 EIF3L RBM14 PNPLA8 TAF5L PC HNRNPLL G6PD TOP2A MGAM2	1.38e-05	1425	164	20	30948266
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ARSJ ATP13A1 DOCK9 ANXA11 PLXNB2 PLEKHG5 BABAM2 CDC14B SLC2A1 TIAM2 TBC1D24 MST1R NLGN2 WDFY3 PC DHX34 WDR24	2.03e-05	1105	164	17	35748872
Pubmed	Tankyrase is necessary for canonical Wnt signaling during kidney development.	TNKS TNKS2	2.21e-05	2	164	2	20549720
Pubmed	Overexpression of CDC14B causes mitotic arrest and inhibits zygotic genome activation in mouse preimplantation embryos.	CDC14C CDC14B	2.21e-05	2	164	2	19923902
Pubmed	Identification of semaphorin 5A interacting protein by applying apriori knowledge and peptide complementarity related to protein evolution and structure.	SEMA5A PLXNB3	2.21e-05	2	164	2	19329067
Pubmed	Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling.	TNKS TNKS2	2.21e-05	2	164	2	27494558
Pubmed	The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway.	CDC14C CDC14B	2.21e-05	2	164	2	21502810
Pubmed	Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells.	SLC2A1 SLC2A4	2.21e-05	2	164	2	24932809
Pubmed	Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells.	TET2 TDG	2.21e-05	2	164	2	34158086
Pubmed	TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells.	TET2 TDG	2.21e-05	2	164	2	28973458
Pubmed	Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein.	CDC14C CDC14B	2.21e-05	2	164	2	18547142
Pubmed	Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.	SLC2A1 SLC2A4	2.21e-05	2	164	2	12712244
Pubmed	Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.	SLC2A1 SLC2A4	2.21e-05	2	164	2	19955252
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	2.21e-05	2	164	2	26807827
Pubmed	Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice.	SLC2A1 SLC2A4	2.21e-05	2	164	2	8798515
Pubmed	Regulation of tankyrase activity by a catalytic domain dimer interface.	TNKS TNKS2	2.21e-05	2	164	2	30055800
Pubmed	Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue.	SLC2A1 SLC2A5	2.21e-05	2	164	2	21938742
Pubmed	Somatic cell-like features of cloned mouse embryos prepared with cultured myoblast nuclei.	SLC2A1 SLC2A4	2.21e-05	2	164	2	12606377
Pubmed	A potential role for glucose transporters in the evolution of human brain size.	SLC2A1 SLC2A4	2.21e-05	2	164	2	21986508
Pubmed	Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice.	SLC2A1 SLC2A4	2.21e-05	2	164	2	7977725
Pubmed	Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons.	NLGN1 NLGN2	2.21e-05	2	164	2	19889999
Pubmed	Fine mapping of murine asthma quantitative trait loci and analyses of Ptgs1 and Mrc1 as positional candidate genes.	MRC1 PTGS1	2.21e-05	2	164	2	17454003
Pubmed	Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.	TNKS TNKS2	2.21e-05	2	164	2	24291818
Pubmed	Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.	SLC2A1 SLC2A4	2.21e-05	2	164	2	2654938
Pubmed	Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development.	TNKS TNKS2	2.21e-05	2	164	2	18612384
Pubmed	Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons.	NLGN1 NLGN2	2.21e-05	2	164	2	10892652
Pubmed	Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy.	TNKS TNKS2	2.21e-05	2	164	2	28723574
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	2.21e-05	2	164	2	31150793
Pubmed	Insulin-sensitive regulation of glucose transport and GLUT4 translocation in skeletal muscle of GLUT1 transgenic mice.	SLC2A1 SLC2A4	2.21e-05	2	164	2	9854024
Pubmed	Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients.	TNKS TNKS2	2.21e-05	2	164	2	18026951
Pubmed	Structural insights into SAM domain-mediated tankyrase oligomerization.	TNKS TNKS2	2.21e-05	2	164	2	27328430
Pubmed	Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.	SLC2A1 SLC2A4	2.21e-05	2	164	2	19648108
Pubmed	The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis.	SLC2A1 SLC2A4	2.21e-05	2	164	2	18796630
Pubmed	NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening.	NLGN1 NLGN2	2.21e-05	2	164	2	29278843
Pubmed	Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.	TNKS TNKS2	2.21e-05	2	164	2	24116873
Pubmed	Induction of DEAD Box helicase 5 in early adipogenesis is regulated by Ten-eleven translocation 2.	TET2 DDX5	2.21e-05	2	164	2	32169654
Pubmed	Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA.	TET2 TDG	2.21e-05	2	164	2	21817016
Pubmed	SEMA5A-PLXNB3 Axis Promotes PDAC Liver Metastasis Outgrowth through Enhancing the Warburg Effect.	SEMA5A PLXNB3	2.21e-05	2	164	2	36741230
Pubmed	Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1.	TNKS TNKS2	2.21e-05	2	164	2	15795250
Pubmed	Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors.	MRC1 GUSB	2.21e-05	2	164	2	17015822
Pubmed	3T3-L1 adipocyte glucose transporter (HepG2 class): sequence and regulation of protein and mRNA expression by insulin, differentiation, and glucose starvation.	SLC2A1 SLC2A4	2.21e-05	2	164	2	2190533
Pubmed	Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake.	SLC2A1 SLC2A4	2.21e-05	2	164	2	28589878
Pubmed	Genetic analysis of attractin homologs.	ATRN ATRNL1	2.21e-05	2	164	2	18064672
Pubmed	Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation.	TNKS TNKS2	2.21e-05	2	164	2	29263426
Pubmed	CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells.	LIF CD9	2.21e-05	2	164	2	11950938
Pubmed	Phosphatidylinositol 3-phosphate [PtdIns3P] is generated at the plasma membrane by an inositol polyphosphate 5-phosphatase: endogenous PtdIns3P can promote GLUT4 translocation to the plasma membrane.	INPP5B SLC2A4	2.21e-05	2	164	2	16880518
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	CARM1 EEFSEC PSMD3 DDX5 EIF3L RBM14 NEIL3 HNRNPLL	2.30e-05	245	164	8	35652658
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	EEFSEC CMYA5 DDX5 PABPN1 RBM14 PNPLA8 SCAF11 HNRNPLL	3.32e-05	258	164	8	37794589
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TET2 VPS13D CNTNAP4 IGSF1 MYO16 PLXNB3	3.69e-05	130	164	6	12421765
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGA11 PCDHGA10 PCDHGA4	4.49e-05	15	164	3	23515096
Pubmed	Family-wide analysis of poly(ADP-ribose) polymerase activity.	PARP14 TNKS TNKS2	5.51e-05	16	164	3	25043379
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ATRN TCF20 PSMD3 SSR3 PLXNB2 SLC2A1 DDX5 TBC1D24 SACM1L CD9 SV2A GLI3 EIF3L IQSEC1 TNKS TAF2 TOP2A	5.84e-05	1203	164	17	29180619
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CARM1 GALC ATP13A1 SPTLC2 ELOVL5 DARS1 SSR3 PLXNB2 PTGS1 SLC2A1 SACM1L FRRS1 GUSB PABPC3 IQSEC1 HTATSF1 NEIL3 G6PD TMEM181	5.85e-05	1451	164	19	30550785
Pubmed	Early-onset aging and defective DNA damage response in Cdc14b-deficient mice.	CDC14C CDC14B	6.61e-05	3	164	2	21262768
Pubmed	Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus.	NLGN1 NLGN2	6.61e-05	3	164	2	22960622
Pubmed	Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators.	CARM1 GRIP1	6.61e-05	3	164	2	11983685
Pubmed	Developmentally Programmed Tankyrase Activity Upregulates β-Catenin and Licenses Progression of Embryonic Genome Activation.	TNKS TNKS2	6.61e-05	3	164	2	32442396
Pubmed	Unique versus Redundant Functions of Neuroligin Genes in Shaping Excitatory and Inhibitory Synapse Properties.	NLGN1 NLGN2	6.61e-05	3	164	2	28607166
Pubmed	Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance.	SLC2A1 SLC2A4	6.61e-05	3	164	2	22971162
Pubmed	The deubiquitinating enzyme USP25 binds tankyrase and regulates trafficking of the facilitative glucose transporter GLUT4 in adipocytes.	SLC2A4 TNKS	6.61e-05	3	164	2	30886164
Pubmed	Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription.	CDC14C CDC14B	6.61e-05	3	164	2	22355704
Pubmed	AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression.	TET2 AHR	6.61e-05	3	164	2	36314527
Pubmed	GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.	SLC2A1 SLC2A4	6.61e-05	3	164	2	22681646
Pubmed	Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes.	SLC2A1 SLC2A4	6.61e-05	3	164	2	12064911
Pubmed	Cloning, expression and chromosomal localization of a new putative receptor-like protein tyrosine phosphatase.	PTPRB PTPRM	6.61e-05	3	164	2	1655529
Pubmed	Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres.	TNKS TNKS2	6.61e-05	3	164	2	11739745
Pubmed	Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3.	SLC2A1 SLC2A4	6.61e-05	3	164	2	22663547
Pubmed	Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits.	NLGN1 NLGN2	6.61e-05	3	164	2	29100073
Pubmed	Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.	SLC2A1 SLC2A4	6.61e-05	3	164	2	17611657
Pubmed	Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle.	SLC2A4 SLC2A5	6.61e-05	3	164	2	16803853
Pubmed	Synaptic Adhesion Molecules Regulate the Integration of New Granule Neurons in the Postnatal Mouse Hippocampus and their Impact on Spatial Memory.	NLGN1 NLGN2	6.61e-05	3	164	2	27473321
Pubmed	Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.	TNKS TNKS2	6.61e-05	3	164	2	25939383
Pubmed	Neuroligins Sculpt Cerebellar Purkinje-Cell Circuits by Differential Control of Distinct Classes of Synapses.	NLGN1 NLGN2	6.61e-05	3	164	2	26291161
Pubmed	Arpin Regulates Migration Persistence by Interacting with Both Tankyrases and the Arp2/3 Complex.	TNKS TNKS2	6.61e-05	3	164	2	33923443
Pubmed	Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders.	GALC GUSB	6.61e-05	3	164	2	20385825
Pubmed	TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression.	TNKS TNKS2	6.61e-05	3	164	2	11454873
Pubmed	Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses.	NLGN1 NLGN2	6.61e-05	3	164	2	17897391
Pubmed	Neuroligins determine synapse maturation and function.	NLGN1 NLGN2	6.61e-05	3	164	2	16982420
Pubmed	Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.	TNKS TNKS2	6.61e-05	3	164	2	21251231
Pubmed	Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α.	CARM1 GRIP1	6.61e-05	3	164	2	26505218
Pubmed	Insulin-stimulated exocytosis of GLUT4 is enhanced by IRAP and its partner tankyrase.	SLC2A4 TNKS	6.61e-05	3	164	2	17059388
Pubmed	Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA.	TET2 TDG	6.61e-05	3	164	2	24838012
Pubmed	Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.	TNKS TNKS2	6.61e-05	3	164	2	26246473
Pubmed	Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer.	SLC2A1 G6PD	6.61e-05	3	164	2	37597521
Pubmed	Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta.	SLC2A1 SLC2A4	6.61e-05	3	164	2	27981520
Pubmed	Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase.	CARM1 GRIP1	6.61e-05	3	164	2	17882261
Pubmed	CDC14B acts through FZR1 (CDH1) to prevent meiotic maturation of mouse oocytes.	CDC14C CDC14B	6.61e-05	3	164	2	19129509
Pubmed	Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism.	NLGN1 NLGN2	6.61e-05	3	164	2	27217145
Interaction	RLN1 interactions	CNTNAP3B CACNA2D2 CNTNAP3 PLXNB2 GUSB COL14A1 NLGN2 TAF5L	8.76e-07	93	163	8	int:RLN1
Interaction	TRGV3 interactions	CNTNAP3B CACNA2D2 CNTNAP3 TEX15 PLXNB2 GUSB	5.33e-06	55	163	6	int:TRGV3
Interaction	LLCFC1 interactions	FAT4 CACNA2D2 CNTNAP3 NLGN1 PLXNB2 TENM3 SULF1 COL14A1	6.39e-06	121	163	8	int:LLCFC1
Interaction	DEFB135 interactions	ATRN CACNA2D2 PLXNB2 ATRNL1 NLGN2	2.17e-05	42	163	5	int:DEFB135
Interaction	BTNL2 interactions	ATRN CNTNAP3B CACNA2D2 CNTNAP3 PLXNB2 MST1R GUSB NLGN2	3.88e-05	155	163	8	int:BTNL2
Interaction	PATE1 interactions	ATRN CACNA2D2 CNTNAP3 PLXNB2 NLGN2	4.66e-05	49	163	5	int:PATE1
Cytoband	3p21.3	XCR1 CACNA2D2 SACM1L MST1R	6.13e-05	59	164	4	3p21.3
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PARP14 TNKS TNKS2	1.29e-04	17	107	3	684
GeneFamily	Zinc fingers GRF-type\|Topoisomerases	APEX2 NEIL3	7.15e-04	7	107	2	135
GeneFamily	Plexins	PLXNB2 PLXNB3	1.22e-03	9	107	2	683
GeneFamily	DNA glycosylases	TDG NEIL3	1.84e-03	11	107	2	1024
GeneFamily	Fibronectin type III domain containing	CMYA5 PTPRB PTPRM COL14A1 USH2A	2.62e-03	160	107	5	555
Coexpression	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	NPR3 ACACB PLXDC1 SPTLC2 SLC38A1 CD9 TENM3 SULF1 COL14A1 RORA G6PD TOP2A	1.69e-05	427	164	12	M17923
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PPP1R21 TET2 ATRN SEC16B GALC SPTLC2 DOCK9 ST8SIA1 ZNF365 JAM2 CD9 PTPRM SV2A RASGEF1B AHR RORA NLGN2 PLEKHM3 CAMSAP2 PLXNB3	1.96e-05	1102	164	20	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PPP1R21 TET2 ATRN SEC16B GALC SPTLC2 DOCK9 ST8SIA1 ZNF365 JAM2 CD9 PTPRM SV2A RASGEF1B AHR RORA NLGN2 PLEKHM3 CAMSAP2 PLXNB3	2.59e-05	1124	164	20	MM1070
Coexpression	GSE27786_CD4_VS_CD8_TCELL_DN	ACER1 CLEC1A TEX15 CDC14B FRRS1 SULF1 EIF3L CYP2U1	3.81e-05	199	164	8	M4821
Coexpression	GSE6875_WT_VS_FOXP3_KO_TREG_DN	PIGN CACNA2D2 DARS1 MST1R IFT88 ATRNL1 TOP2A IPO11	3.81e-05	199	164	8	M6804
Coexpression	GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	TMPRSS15 SPTLC2 ODF2 PLXNB2 DNAH7 SLC2A1 NUDT3 ATRNL1	3.95e-05	200	164	8	M5195
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200	TET2 MRC1 NPR3 GALC CLEC1A SEMA5A COL14A1 TNKS2 CAMSAP2	4.60e-06	164	161	9	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3	MRC1 APH1B GALC DUSP3 PLXNB2 CDC14B PTGS1 DENND4C JAM2 CD9 PTPRM GUSB RASGEF1B WDFY3	7.11e-06	441	161	14	GSM605862_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2	MRC1 APH1B XCR1 CLEC1A JAM2 PTPRB GUSB RASGEF1B AHR PLEKHM3 WDFY3 TOP2A	7.00e-05	409	161	12	GSM538234_500
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500	TET2 MRC1 NPR3 GALC CLEC1A SEMA5A ST8SIA1 C4orf54 ATRNL1 COL14A1 TNKS2 CAMSAP2	7.50e-05	412	161	12	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	FAT4 NPR3 CLEC1A SEMA5A CDC14B ZNF365 TIAM2 TBC1D24 SULF1 GLI3 RASGEF1B RBM14 AHR RORA TNKS TNKS2 CAMSAP2	7.86e-05	769	161	17	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 DNAI3 GRIP1 PTPRM SULF1 PLD5 MYO16	1.49e-09	181	164	10	bd7e9437839bca543ca5945df43d6525e6a312a8
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1 PLD5 MYO16	1.65e-09	183	164	10	04d3cc76038b8192c915f1c08c3e26f2ad3b3779
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1 PLD5 MYO16	2.38e-09	190	164	10	3f22c118d552345f731d4d49f0bcb5765d93de3b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1 PLD5 MYO16	2.38e-09	190	164	10	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 ST8SIA1 GRIP1 TENM3 PTPRM SULF1 MYO16	2.38e-09	190	164	10	8c9c230a509afaeee50644153974a5642b01a2b8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1 PLD5 MYO16	2.38e-09	190	164	10	0acf1d5da68db449d8c9e70519a236ce825f9d11
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 KCNIP1 GRIP1 TENM3 PTPRM SULF1 MYO16	2.50e-09	191	164	10	782bc7946417549ffd39e5b596db659436fa01ba
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 KCNIP1 GRIP1 TENM3 PTPRM SULF1 MYO16	2.76e-09	193	164	10	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1 PLD5 MYO16	2.76e-09	193	164	10	c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR3 NLGN1 PTGS1 TIAM2 TBC1D24 JAM2 FAT2 TENM3 CNTNAP4	1.96e-08	176	164	9	27e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B NPR3 DOCK9 CNTNAP3 CLEC1A JAM2 PTPRB CD9 SULF1	2.17e-08	178	164	9	c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 GRIP1 TENM3 PTPRM SULF1 PLD5 MYO16	3.47e-08	188	164	9	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRTAC1 TEX15 KCNIP1 GRIP1 PTPRM SULF1 CNTNAP4 COL14A1 MYO16	3.47e-08	188	164	9	3139540a656c0436b2123ea50741ff8d00112165
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	CNTNAP3B NPR3 DOCK9 CNTNAP3 CLEC1A JAM2 PTPRB PTPRM SULF1	3.64e-08	189	164	9	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1 MYO16	3.64e-08	189	164	9	99a13b1b669b0cd36e3096632351d9ade25d1173
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1 MYO16	3.81e-08	190	164	9	e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	CNTNAP3B NPR3 DOCK9 CNTNAP3 PTGS1 OPCML PTPRB CD9 RASGEF1B	4.16e-08	192	164	9	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 GRIP1 TENM3 PTPRM SULF1 PLD5 MYO16	4.16e-08	192	164	9	0003d7ef9a8e521e70ac33c63aad843d9b6215c2
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B NPR3 DOCK9 CLEC1A SLC2A1 JAM2 PTPRB CD9 AHR	4.55e-08	194	164	9	3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 KCNIP1 GRIP1 TENM3 PTPRM SULF1	4.55e-08	194	164	9	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTNAP3B FAT4 NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM DISP1	5.42e-08	198	164	9	d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 PTPRM SULF1 PLD5 MYO16	5.91e-08	200	164	9	4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 PTPRM SULF1 PLD5 MYO16	5.91e-08	200	164	9	fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 PTPRM SULF1 PLD5 MYO16	5.91e-08	200	164	9	c6eda342ea0cb37d71d89dbb8d11e819e0745172
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CACNA2D2 CNTNAP3 KCNIP1 PTGS1 GRIP1 PTPRM CNTNAP4 MYO16	1.54e-07	161	164	8	b81b346309f3facbfbebd91cae4c5b33c7bd24ef
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 KCNIP1 GRIP1 TENM3 PTPRM SULF1 AHR	3.04e-07	176	164	8	322259a35f5c97d73ce7f75835dcdb5c954c91f8
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 PLD5 MYO16	3.04e-07	176	164	8	682a1dfcc507ec540f5fadf08e872533ea9f0291
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 TENM3 PTPRM SULF1 PLD5 MYO16	3.45e-07	179	164	8	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 PLD5 MYO16	4.08e-07	183	164	8	d2074b13b4831ec18c81273d9a1ff673c3f6a16d
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B NPR3 DOCK9 CNTNAP3 CLEC1A JAM2 PTPRB CD9	4.26e-07	184	164	8	a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 PLD5 MYO16	4.44e-07	185	164	8	f4ac62009c0ad3346e71b809e17727303c4df153
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 GRIP1 PTPRM SULF1 PLD5 MYO16	4.62e-07	186	164	8	6379609b7ace80683f5754b16aa77f11b43766ae
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 GRIP1 PTPRM SULF1 PLD5 MYO16	4.81e-07	187	164	8	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	Control-Endothelial_cells-Arterial_endothelial_cells\|Control / group, cell type (main and fine annotations)	CNTNAP3B NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM SULF1	4.81e-07	187	164	8	81affaab3fe3e1daea45ada6445e906ddd33950e
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	CNTNAP3B FAT4 NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM	5.01e-07	188	164	8	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B FAT4 NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM	5.01e-07	188	164	8	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B NPR3 DOCK9 CNTNAP3 PTGS1 OPCML PTPRB CD9	5.22e-07	189	164	8	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 PTPRM SULF1 MYO16	5.22e-07	189	164	8	78cf414b98bcb19deb934409acddaad1cd51b67f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1	5.43e-07	190	164	8	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 GRIP1 TENM3 PTPRM SULF1 MYO16	5.43e-07	190	164	8	39ab890104b4264c68a968f920f4ccd84f0bc681
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B FAT4 NPR3 DOCK9 JAM2 PTPRB PTPRM SULF1	5.43e-07	190	164	8	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3B NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM SULF1	5.65e-07	191	164	8	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLEC1A CMYA5 JAM2 TENM3 SULF1 CNTNAP4 RORA LGI1	6.11e-07	193	164	8	7cd9671e0ac64f7f3607f564485c63abbb7e7a63
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	CNTNAP3B NPR3 DOCK9 PARP14 PTGS1 OPCML PTPRB CD9	6.11e-07	193	164	8	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1	6.11e-07	193	164	8	53bcd50892c379b2a571751f6eb1062436339fe7
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	CNTNAP3B NPR3 DOCK9 PARP14 PTGS1 OPCML PTPRB CD9	6.11e-07	193	164	8	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B FAT4 NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM	6.36e-07	194	164	8	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3B NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM SULF1	6.61e-07	195	164	8	023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell	PCW_13-14-Endothelial-Endothelial_mature\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B NPR3 DOCK9 CNTNAP3 CLEC1A JAM2 PTPRB CD9	6.61e-07	195	164	8	31353269591c9eee84872838e91995d4a035da46
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B NPR3 DOCK9 CLEC1A SLC2A1 JAM2 PTPRB CD9	6.87e-07	196	164	8	2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b
ToppCell	PCW_10-12-Endothelial-Endothelial_mature\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B NPR3 DOCK9 CNTNAP3 CLEC1A JAM2 PTPRB CD9	6.87e-07	196	164	8	481d79bdaec069ad2746a28d39eeee8d3edf7305
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	CNTNAP3B FAT4 NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM	7.14e-07	197	164	8	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	CNTNAP3B NPR3 DOCK9 CLEC1A JAM2 PTPRB PTPRM RASGEF1B	7.70e-07	199	164	8	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK9 SEMA5A CRTAC1 KCNIP1 CSMD3 OPCML ATRNL1 PLXNB3	7.70e-07	199	164	8	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK9 SEMA5A CRTAC1 CMYA5 KCNIP1 CSMD3 OPCML ATRNL1	7.70e-07	199	164	8	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK9 SEMA5A CRTAC1 KCNIP1 CSMD3 OPCML ATRNL1 PLXNB3	7.70e-07	199	164	8	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	CATSPERD NLGN1 CMYA5 OPCML SV2A SULF1 COL14A1	7.77e-07	137	164	7	a69976938d4e89315ec0be3a332b91ddf3799d65
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CRTAC1 TEX15 KCNIP1 GRIP1 SULF1 GLI3 COL14A1 MYO16	8.00e-07	200	164	8	ca5401b76ab014080914bf78042d368cf318effa
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 PLD5 MYO16	8.00e-07	200	164	8	3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 GRIP1 PTPRM SULF1 PLD5 MYO16	8.00e-07	200	164	8	1276bfa911fddada4235e12e3081baa53164574b
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 PLD5 MYO16	8.00e-07	200	164	8	97a010a1b6d551239cf6ea5a43319fb413ff180e
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 KCNIP1 GRIP1 TENM3 PTPRM SULF1 MYO16	8.00e-07	200	164	8	5ec469267747dce3601c1d8ad01af89fa5b29acc
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTLC2 DOCK9 PARP14 JAM2 PTPRB CD9 PTPRM DISP1	8.00e-07	200	164	8	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DOCK9 PARP14 JAM2 CD9 PTPRM AHR DDX60L DISP1	8.00e-07	200	164	8	89821a264e872ed53e08e9d3609d5cc5c314503e
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CRTAC1 TEX15 KCNIP1 GRIP1 SULF1 GLI3 COL14A1 MYO16	8.00e-07	200	164	8	70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ATP8A2 CRTAC1 TEX15 KCNIP1 GRIP1 PTPRM CNTNAP4 MYO16	8.00e-07	200	164	8	e90155498397524b812c46f2412320230b445bb6
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 PLD5 MYO16	8.00e-07	200	164	8	8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 KCNIP1 GRIP1 TENM3 PTPRM SULF1 MYO16	8.00e-07	200	164	8	e79d93d55b25804f2608185168da472301b6ebca
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CRTAC1 TEX15 KCNIP1 GRIP1 SULF1 GLI3 COL14A1 MYO16	8.00e-07	200	164	8	40286010bd17cf9e34ecd5440953b072ebfae208
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 GRIP1 TENM3 PTPRM SULF1	8.00e-07	200	164	8	107854f4855fc99c9f7e737eb246f0d868e6c5fd
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FAT4 NPR3 DOCK9 PLEKHG5 JAM2 PTPRB PTPRM AHR	8.00e-07	200	164	8	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTLC2 DOCK9 PARP14 JAM2 PTPRB CD9 PTPRM DISP1	8.00e-07	200	164	8	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	Neuronal-Inhibitory-iB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CACNA2D2 CNTNAP3 KCNIP1 GRIP1 TENM3 PTPRM SULF1	8.00e-07	200	164	8	45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 KCNIP1 GRIP1 TENM3 PTPRM SULF1 MYO16	8.00e-07	200	164	8	320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TMPRSS15 ATP8A2 CSMD3 OPCML ATRNL1 CNTNAP4 USH2A	1.31e-06	148	164	7	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TMPRSS15 ATP8A2 CSMD3 OPCML ATRNL1 CNTNAP4 USH2A	1.43e-06	150	164	7	0205318a870e091add66ee4305747dda9f51510d
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	ACER1 DOCK9 ZNF365 SLC2A1 VPS13D FAT2 FRRS1	1.86e-06	156	164	7	ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	CATSPERD ATP8A2 CSMD3 OPCML CNTNAP4 USH2A MYO16	2.48e-06	163	164	7	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SEMA5A KCNIP1 JAM2 PTPRM COL14A1 RORA PLD5	2.48e-06	163	164	7	8d17f44faf0549fe71a9a45f811f50d767275414
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SEMA5A CRTAC1 KCNIP1 JAM2 PTPRM RORA PLD5	2.59e-06	164	164	7	08819970174a3eb4eee8e1e675075828665b845e
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK9 DUSP3 CLEC1A JAM2 PTPRB PTPRM AHR	3.83e-06	174	164	7	cb0109661e8c9ca04d67d33f2d926f0e649bf67d
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRAV12-3 NLGN1 KCNIP1 DNAH7 GRIP1 TENM3 ATRNL1	4.45e-06	178	164	7	544379f5a6145429762258d426b876bb36c112f5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B SEMA5A LAMC2 CRTAC1 KCNIP1 TENM3 PLD5	4.45e-06	178	164	7	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MRC1 CNTNAP3B DOCK9 CNTNAP3 KCNIP1 SLC38A1 PTPRB	4.61e-06	179	164	7	ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MRC1 CNTNAP3B DOCK9 CNTNAP3 KCNIP1 SLC38A1 PTPRB	4.61e-06	179	164	7	35fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B FAT4 ACACB DOCK9 JAM2 PTPRB PTPRM	4.61e-06	179	164	7	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B FAT4 NPR3 CNTNAP3 CLEC1A JAM2 PTPRB	4.78e-06	180	164	7	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 MYO16	5.15e-06	182	164	7	08aff7112c9dac0ef5540300516a604782b21169
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DOCK9 CLEC1A PLEKHG5 JAM2 PTPRB PTPRM AHR	5.15e-06	182	164	7	fec1caf867b1dc87b24504d895ee1a27df78062e
ToppCell	Hippocampus-Neuronal-Inhibitory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CACNA2D2 CNTNAP3 KCNIP1 GRIP1 PTPRM PLD5 MYO16	5.15e-06	182	164	7	b54ae650c04dfd0759c5f5e752b9bf684dd36516
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 CRTAC1 PTPRM SULF1 MYO16	5.15e-06	182	164	7	a3c5c0eff527c8d3848acda14af8f9e99c69b0de
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CACNA2D2 CNTNAP3 PTPRM SULF1 PLD5 MYO16	5.33e-06	183	164	7	121791ef84e7ce377ed6f5b7953af8865e04958e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ELOVL5 NLGN1 KCNIP1 PTPRM RORA PLD5 MYO16	5.53e-06	184	164	7	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	Endothelial-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CNTNAP3B NPR3 CNTNAP3 OPCML JAM2 PTPRB SULF1	5.73e-06	185	164	7	ae49c61f6ecf128fe2a958b8c75c83688da75f59
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MRC1 CNTNAP3B DOCK9 CNTNAP3 KCNIP1 SLC38A1 PTPRB	5.73e-06	185	164	7	3be9e05b929ac4d956b1d53284072f668a6c1959
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B FAT4 DOCK9 CNTNAP3 JAM2 PTPRB SULF1	5.73e-06	185	164	7	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 CMYA5 JAM2 CNTNAP4 COL14A1 USH2A MYO16	5.73e-06	185	164	7	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MRC1 CNTNAP3B DOCK9 CNTNAP3 KCNIP1 SLC38A1 PTPRB	5.73e-06	185	164	7	c3dd64a726cb8a1fe048683c266b7532a714a52e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CRTAC1 PTPRM SULF1 GLI3 MYO16	5.93e-06	186	164	7	948815663c212c4311329d503b5991cbbbff9808
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARSJ DOCK9 TIAM2 JAM2 PTPRB SULF1 CNTNAP4	5.93e-06	186	164	7	2d3a975d2bf92e18e3410dd413fc9f84831d82de
Computational	Neighborhood of ITGA2	ST8SIA1 OPCML PTPRB SLC15A1 COL14A1 LGI1	1.24e-05	56	100	6	MORF_ITGA2
Disease	amino acid measurement	PIGN FAT4 ACACB ZNF596 CNTNAP3 SEMA5A NLGN1 ST8SIA1 DNAH7 SLC2A4 SLC38A1 PTPRB COL14A1 TNKS2 HNRNPLL MYO16 MGAM2	1.69e-07	678	159	17	EFO_0005134
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP3B TCF20 CNTNAP3 LAMC2 NLGN1 CNTNAP4 NLGN2 WDFY3	1.81e-06	152	159	8	DOID:0060041 (implicated_via_orthology)
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3 CNTNAP4	8.43e-06	8	159	3	DOID:0060308 (implicated_via_orthology)
Disease	nonsyndromic deafness (is_implicated_in)	TBC1D24 USH2A	2.89e-05	2	159	2	DOID:0050563 (is_implicated_in)
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	FAT4 ELOVL5 LGI1	5.35e-05	14	159	3	EFO_0004670, EFO_0006794
Disease	colorectal cancer, hormone replacement therapy	OPCML LIG4 SLC15A1 DISP1 MYO16	1.17e-04	88	159	5	EFO_0003961, MONDO_0005575
Disease	Insulin Resistance	MRC1 ACACB SLC2A4 AHR	3.13e-04	60	159	4	C0021655
Disease	Insulin Sensitivity	MRC1 ACACB SLC2A4 AHR	3.13e-04	60	159	4	C0920563
Disease	cortical surface area measurement	TET2 ATP8A2 DOCK9 SEMA5A CRTAC1 PLXNB2 DNAH7 SACM1L GRIP1 SLC38A1 GLI3 RASGEF1B RORA TNKS PLEKHM3 PC CTSO MYO16	3.56e-04	1345	159	18	EFO_0010736
Disease	bitter non-alcoholic beverage consumption measurement	SEC16B ZNF365 AHR	6.79e-04	32	159	3	EFO_0010093
Disease	cervix carcinoma (is_marker_for)	PTGS1 CD9	7.91e-04	8	159	2	DOID:2893 (is_marker_for)
Disease	dynein light chain roadblock-type 1 measurement	TRIM58 CDC14B	7.91e-04	8	159	2	EFO_0008114
Disease	memory impairment	FAT4 LRRC37B	7.91e-04	8	159	2	EFO_0001072
Disease	plexin-B2 measurement	MRC1 PLXNB2	1.01e-03	9	159	2	EFO_0021867
Disease	Developmental delay (disorder)	TCF20 CACNA2D2 SLC2A1	1.04e-03	37	159	3	C0424605
Disease	Malignant neoplasm of liver	SLC2A1 CIDEA IFT88 AHR TOP2A	1.06e-03	142	159	5	C0345904
Disease	Liver neoplasms	SLC2A1 CIDEA IFT88 AHR TOP2A	1.06e-03	142	159	5	C0023903
Disease	Creutzfeldt-Jakob disease (is_marker_for)	GALC PTGS1	1.26e-03	10	159	2	DOID:11949 (is_marker_for)
Disease	Asthma, Occupational	PTGS1 TENM3	1.26e-03	10	159	2	C0264423
Disease	epilepsy	TNKS CAMSAP2 C1orf94	1.41e-03	41	159	3	EFO_0000474
Disease	1-methylxanthine measurement	SLC38A1 AHR	1.54e-03	11	159	2	EFO_0021174
Disease	coffee consumption measurement, tea consumption measurement	TET2 AHR RORA	1.73e-03	44	159	3	EFO_0006781, EFO_0010091
Disease	ceramide measurement	SEC16B ARSJ SPTLC2 PSMD3 NLGN1 RORA	1.78e-03	235	159	6	EFO_0010222
Disease	Gastrointestinal Stromal Sarcoma	IFT88 GLI3 DISP1	2.09e-03	47	159	3	C3179349
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	ACACB CRTAC1 SLC38A1 TNKS TNKS2	2.10e-03	166	159	5	EFO_0004530, EFO_0004611
Disease	Weight Gain	NPR3 VPS13D AHR IPO11	2.29e-03	102	159	4	C0043094
Disease	developmental disorder of mental health (implicated_via_orthology)	PLXNB2 PLXNB3 NCKAP1L	2.36e-03	49	159	3	DOID:0060037 (implicated_via_orthology)
Disease	Gastrointestinal Stromal Tumors	IFT88 GLI3 DISP1	2.50e-03	50	159	3	C0238198
Disease	indolelactate measurement	ODF2 SULF1	2.52e-03	14	159	2	EFO_0020012
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	ACACB CRTAC1 SLC38A1 TNKS	2.63e-03	106	159	4	EFO_0008317, EFO_0008596
Disease	response to simvastatin, total cholesterol change measurement, response to fenofibrate	DARS1 NLGN1 RASGEF1B	2.65e-03	51	159	3	EFO_0007806, GO_1901557, GO_1903491
Disease	nasopharynx carcinoma (is_implicated_in)	TET2 MST1R	2.89e-03	15	159	2	DOID:9261 (is_implicated_in)
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	ACACB CRTAC1 SLC38A1 TNKS	3.01e-03	110	159	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	ACACB CRTAC1 SLC38A1 TNKS	3.01e-03	110	159	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	ACACB CRTAC1 SLC38A1 TNKS	3.01e-03	110	159	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	coffee consumption measurement	TET2 SEC16B CACNA2D2 OPCML AHR	3.13e-03	182	159	5	EFO_0006781
Disease	Tremor, Rubral	CACNA2D2 SLC2A1	3.29e-03	16	159	2	C0750940
Disease	Ataxia, Appendicular	CACNA2D2 SLC2A1	3.29e-03	16	159	2	C0750937
Disease	Ataxia, Motor	CACNA2D2 SLC2A1	3.29e-03	16	159	2	C0278161
Disease	Ataxia, Sensory	CACNA2D2 SLC2A1	3.29e-03	16	159	2	C0240991
Disease	4-acetamidobutanoate measurement	PLXNB2 SLC38A1	3.29e-03	16	159	2	EFO_0021003
Disease	coffee consumption, cups of coffee per day measurement	OPCML AHR	3.29e-03	16	159	2	EFO_0004330, EFO_0006782
Disease	Abnormal coordination	CACNA2D2 SLC2A1	3.29e-03	16	159	2	C0520966
Disease	methylcobalamin deficiency type cblE, brain serotonin transporter measurement	SLC38A1 CD9	3.29e-03	16	159	2	EFO_0004569, MONDO_0009354
Disease	Ataxia, Truncal	CACNA2D2 SLC2A1	3.29e-03	16	159	2	C0427190
Disease	alkaline phosphatase measurement	NBPF3 TET2 SEC16B ACACB ATP13A1 BABAM2 SLC2A4 SLC38A1 GUSB GLI3 TNKS NLGN2 TNKS2	3.48e-03	1015	159	13	EFO_0004533
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	PPP1R21 SEC16B CRTAC1 NLGN1 MST1R RORA TNKS	3.70e-03	364	159	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	caudal anterior cingulate cortex volume measurement	TMPRSS15 FAT2	3.72e-03	17	159	2	EFO_0010289
Disease	peripheral neuropathy, response to docetaxel trihydrate	ATP8A2 OPCML	4.65e-03	19	159	2	EFO_0003100, GO_1902519
Disease	cognitive function measurement	SEC16B ARSJ TCF20 CACNA2D2 CNOT10 CSMD3 PLXNB2 CDC14B OPCML SLC38A1 MST1R GLI3 CNTNAP4 TNKS TAF2 USH2A	4.74e-03	1434	159	16	EFO_0008354
Disease	Myopia	APH1B DOCK9 SLC2A5 RASGEF1B CNTNAP4 PNPLA8 DDX60L	5.01e-03	385	159	7	HP_0000545
Disease	multiple sclerosis	TET2 GALC KCNIP1 PLEKHG5 SLC2A4 SLC38A1 MMEL1 TSPAN31 RORA	5.06e-03	594	159	9	MONDO_0005301
Disease	diet measurement, body mass index	CMYA5 LGI1	5.14e-03	20	159	2	EFO_0004340, EFO_0008111

Protein segments in the cluster

Peptide	Gene	Start	Entry
AGSYSLQQAQAFYTF	TDG	6	Q13569
DISVFYQSSFQDYNA	ACCSL	141	Q4AC99
FYASSTIQDYLGFQQ	AHR	136	P35869
AQTFISSYYGINLAS	APH1B	201	Q8WW43
FYEEYLSVILANNGS	CNTNAP3	1061	Q9BZ76
NVATYAGQFNQDYLS	ANXA11	41	P50995
EVNGQFSYSYSLTAQ	CATSPERD	606	Q86XM0
SYEGFNITFSEYNLE	CSMD3	1166	Q7Z407
YKAGFEYAFDQLQNS	CACNA2D2	371	Q9NY47
ESNFQYSELVAEFYN	ACER1	16	Q8TDN7
QYGFLNFNSFNLDEY	CDC14B	191	O60729
TFYNLGTALYYATQN	APOF	191	Q13790
VGNAFSYYQSNRGFQ	ATP13A1	196	Q9HD20
NRPLFNSTNYTFYFE	FAT4	1096	Q6V0I7
YYIASGNLGNTFQID	FAT4	2601	Q6V0I7
FYNSSYLNVQRENGT	ORM2	91	P19652
SGSSVIYNFQENYLL	CNTNAP4	1006	Q9C0A0
VFTNHSTFLQYQGLY	C1orf94	471	Q6P1W5
AIVEGYNSYFSFSRN	APEX2	61	Q9UBZ4
FSSKQQFIATADYYG	DNAI3	771	Q8IWG1
QYGFLNFNSFNLDEY	CDC14C	161	A4D256
AAAFYANYVSNITAI	DISP1	616	Q96F81
ATNNSDYAIAQFSYL	ATP8A2	846	Q9NTI2
SGDYAFFNIELFNSS	NPR3	281	P17342
FSATFDYQQAFGNST	RBM14	181	Q96PK6
FFARNSYVAGQYDDA	G6PD	101	P11413
VYIAGQQAFFNYSTS	HNRNPLL	136	Q8WVV9
NTGVLYALQSFDYEQ	PCDHGA11	511	Q9Y5H2
RFQAQTLGTTYIYDF	ACACB	1706	O00763
IDQTAIGSYYQLFAA	ANKRD53	101	Q8N9V6
YQLNSNGYFSLDVQS	PCDHGA4	201	Q9Y5G9
NEYTFFNLTAGSKYN	PTPRB	166	P23467
TFTILNFQGNYISYI	LRRC37A3	866	O60309
LQNYSGQFYDQTVGF	GLI3	1436	P10071
TFTILNFQGNYISYI	LRRC37A2	866	A6NM11
TFTILNFQGNYISYI	LRRC37A	866	A6NMS7
SQNVLSLFNGYVYSG	NEIL3	61	Q8TAT5
SIDTYENGNYFLANF	MGAM2	1711	Q2M2H8
SQQLSGINAVFYYST	SLC2A1	281	P11166
DTFDNFYVSAQLQYI	MYO16	1051	Q9Y6X6
LSQQLSGINAVFYYS	SLC2A4	296	P14672
SLIALFTNFYIQTYN	ELOVL5	241	Q9NYP7
IIDEFIYQFQSFSQY	EIF3L	186	Q9Y262
NGSANALFILYYTAQ	LIF	56	P15018
FYNNSIIIYSSDNGG	ARSJ	316	Q5FYB0
FSDAAYNLTGFNITY	ATRN	231	O75882
NSVTYSFRQSFSLYG	IQSEC1	796	Q6DN90
NGYIFLSSTEFLQTY	IPO11	711	Q9UI26
ESDYVGFNATYTAFN	TMPRSS15	321	P98073
GFNATYTAFNSSELN	TMPRSS15	326	P98073
QNGVYSAANYTNGSF	DDX5	531	P17844
QDYQQFYGKSLESIS	DDX60L	521	Q5H9U9
TEESSAVQYFQFYGY	CARM1	141	Q86X55
YSNILQQSGTNKEFY	FSIP2	6426	Q5CZC0
YKAGYLSTNTQQFVA	PLXNB2	206	O15031
DFSDYNNSYVGAFAD	PLXNB3	226	Q9ULL4
NNSYVGAFADARSAY	PLXNB3	231	Q9ULL4
DLGQNAEFYYAFNTR	FAT2	176	Q9NYQ8
QASYFETLRQGYSAN	NUDT3	136	O95989
FSQVSYFTYIPENNA	PCDHGA10	456	Q9Y5H3
SSFYSIEKDGYNNNI	NCKAP1L	1016	P55160
GSSFIQHYYQLFDND	NUTF2	11	P61970
IFTTLNFQGNYISYL	LRRC37B	556	Q96QE4
SFVYYQQTLQGDFKN	JAM2	71	P57087
FDFAVSNFVDNLYGY	NLGN1	451	Q8N2Q7
VGSQEYSYEQFLFNT	PTGS1	396	P23219
YFYSLDSSGNQNLYA	PLEKHM3	241	Q6ZWE6
FFSNNLDYFIASLSY	PPP1R21	486	Q6ZMI0
YSNLNFSEDLYFENS	MMEL1	526	Q495T6
FDSSGYNRNLYQSAE	RASGEF1B	11	Q0VAM2
YAHYLFNAFDTTQTG	KCNIP1	101	Q9NZI2
LITSGSSNYAYVNFQ	PABPC3	46	Q9H361
SVSFNGQAECYYFAN	PANK3	151	Q9H999
DFIATYQANYGFSND	HTATSF1	66	O43719
LTFFNVSEKDYGNYT	OPCML	281	Q14982
KGTYFAVNANYSAND	PARP14	1711	Q460N5
YFQLHASFQQYRSAF	NBPF3	581	Q9H094
ASFQQYRSAFYSFEE	NBPF3	586	Q9H094
TNYNSSRSRFYSGFN	PABPN1	271	Q86U42
NNSNSSFDEEYLFYI	CYP2U1	331	Q7Z449
LRFNFYTSQYSNSLN	GUCA1ANB	76	X6R8D5
NNNSSFYTGVYILIG	CD9	51	P21926
SFFLNNVTYSDTGIY	IGSF1	376	Q8N6C5
TFIQAGQYSDAINSY	IFT88	281	Q13099
TYFRVAFFGQAAQYQ	DOCK9	1781	Q9BZ29
FSRNGYNYTDQFGAS	LIG4	291	P49917
TFQSVYHFTNSGQLY	BABAM2	326	Q9NXR7
KTLTYFNYDQSGDFQ	COL14A1	1326	Q05707
NTSYYIFLADGAAND	FRRS1	321	Q6ZNA5
VQNTYFDFFNYAGLQ	GUSB	201	P08236
NYFFYVRAINAFGTS	CMYA5	3871	Q8N3K9
AYLGAFTSTYRQNQT	DNAH7	2916	Q8WXX0
AFDNEYGIAYNSLSS	DENND4C	1866	Q5VZ89
AYNLTGFNIFYSINS	ATRNL1	196	Q5VV63
VNTNANFYKDSGITY	DUSP3	71	P51452
YIQNFRFFAGTYNVN	INPP5B	341	P32019
FEQLVSIGSSYNYGN	KCTD5	181	Q9NXV2
QQVSYGQSLSFDYRV	LAMC2	261	Q13753
YFLNTNNAFSGVATY	CRTAC1	131	Q9NQ79
QGTSFQASGYNFNTY	GRIP1	821	Q9Y3R0
DNNVIYSFVDYASFG	C4orf54	396	D6RIA3
NFADQTGVFEYFTNI	GALC	506	P54803
FESLSQYGSQVGYQI	DHX34	226	Q14147
GTYRSSFAYKDQNEN	SCAF11	1081	Q99590
VYANISSYNASTYQF	SLC15A1	506	P46059
YYKNNFSDGFRQDSI	SACM1L	481	Q9NTJ5
LQFYLYNSGSESDQL	MEP1B	341	Q16820
FDFTVSNFVDNLYGY	NLGN2	406	Q8NFZ4
IYGRFSQDEYSLNQA	PKD1L1	2301	Q8TDX9
AAYSYFQIGAIQSFA	ATP4A	861	P20648
AQQYSAFFQATDLPY	CAMSAP2	161	Q08AD1
FYEEYLSVILANNGS	CNTNAP3B	1061	Q96NU0
NASLLNSQYYFAAEF	PTPRM	651	P28827
YVQFLKSSYANVFGD	ODF2	796	Q5BJF6
EGAFENTLYFNSQSS	MRC1	1421	P22897
GDSFYFLSNHINSYF	PNPLA8	201	Q9NP80
FYAFYNTEQLLNTAE	TAF5L	261	O75529
GYNNFYNTPSLQEFV	USH2A	466	O75445
VGANFYSSVKQQDYS	PLD5	36	Q8N7P1
YNDFVNISSIGLTYF	LIPI	391	Q6XZB0
RNLNYFSNAYAAAVS	TAF2	101	Q6P1X5
FGSSFQYGYNVAAVN	SLC2A5	26	P22732
NTAGTQFLSAAYDRY	CDC40	341	O60508
FTEAYESGQNQAYSL	SHLD2	296	Q86V20
YYTLSDVGANQTVLF	ST8SIA1	236	Q92185
GANVFTVSYFKNNAY	DARS1	231	P14868
YFTRQYGDESTLAFQ	PI4KAP2	406	A4QPH2
YGDESTLAFQQARYN	PI4KAP2	411	A4QPH2
YEATTFSIFYNNTLF	SSR3	131	Q9UNL2
VNSVFAFFSSFVQGY	SV2A	241	Q7L0J3
TGKTYSNAYFTDLNN	SEMA5A	1056	Q13591
NYSQNDLIGQSLFDY	ARNTL	181	O00327
ENSTAFYGINQFSYL	CTSO	61	P43234
FLSYSAQVTGQFLIY	CIDEA	176	O60543
LFFQYYQLSNTGQDT	CLEC1A	71	Q8NC01
TFYNSISNPYQTFLG	CLRN3	111	Q8NCR9
STNAFQAFTSGNYDA	CNOT10	31	Q9H9A5
SSLQHGYSLARFYFQ	TBC1D24	371	Q9ULP9
YLNEFHSAVGAYTFQ	PLEKHG5	651	O94827
NPESTTFFYYDLQSQ	XCR1	6	P46094
GYFNFTSATITYLAQ	SSR2	101	P43308
SFNFSQEYLFQEQYL	EEFSEC	366	P57772
SYGSHLFDYAFIQNS	ZNF596	166	Q8TC21
YYQSQQASGFVRDLS	ZNF365	291	Q70YC5
GSYQVLVNNVFYFTQ	WDFY3	2036	Q8IZQ1
VSLNCTYSNSAFQYF	TRAV12-3	41	A0A0B4J271
YVLYKAVQGFFTSNN	PSMD3	111	O43242
SNSFGDVYLFQATSQ	TIAM2	591	Q8IVF5
AFDSQNNTVYFDGKY	RORA	371	P35398
FVSLYQDFENFYTRN	SPTLC2	111	O15270
HYQNSAEFLSFYGLL	TMEM181	531	Q9P2C4
GIYFAENSSKSNQYV	TNKS	1211	O95271
IQAAFLNESQFQYFY	TTC41P	166	Q6P2S7
LNESQFQYFYFRTGT	TTC41P	171	Q6P2S7
GLFNLTTLYQQDYDF	TSPAN31	131	Q12999
SLGQHLQFFYADLTY	TENM3	2241	Q9P273
QRFSQSGQSYDGSYN	TCF20	251	Q9UGU0
QFSYNTDITQFRQLY	PIGN	766	O95427
FAENSSKSNQYVYGI	TNKS2	1061	Q9H2K2
NTFYQDFSGCQGYSE	SEC16B	736	Q96JE7
YGQTTTYLTYNDFIN	TOP2A	686	P11388
NFNPGYSDNSTVVYF	PLXDC1	181	Q8IUK5
YFTFASTFENGNVQL	WDR24	176	Q96S15
AQGTHSNLLYSQYFT	TEX15	2701	Q9BXT5
SNLLYSQYFTYFAGE	TEX15	2706	Q9BXT5
NFYSTSSQAAGSYLN	TET2	1596	Q6N021
FAVYLNNTGYRTAFF	SULF1	126	Q8IWU6
NYTRAYSEALAAFGN	PC	216	P11498
QGQASYFYVASSLDA	MST1R	191	Q04912
AIFGYLTFYDNVQSD	SLC38A1	326	Q9H2H9
NVTDGSYIYTFNQLF	TRIM58	426	Q8NG06
NFIYIAATYTFSGLQ	VPS13D	3591	Q5THJ4
NYQYAILGSDYSFTQ	LGI1	486	O95970